Compare IMRX & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMRX | WEYS |
|---|---|---|
| Founded | 2008 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.7M | 334.8M |
| IPO Year | 2021 | 1995 |
| Metric | IMRX | WEYS |
|---|---|---|
| Price | $5.27 | $33.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $17.20 | N/A |
| AVG Volume (30 Days) | ★ 750.7K | 12.1K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.11% |
| EPS Growth | ★ 37.75 | N/A |
| EPS | N/A | ★ 2.41 |
| Revenue | N/A | ★ $276,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.22 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.10 | $27.25 |
| 52 Week High | $10.08 | $35.18 |
| Indicator | IMRX | WEYS |
|---|---|---|
| Relative Strength Index (RSI) | 45.18 | 46.70 |
| Support Level | $4.66 | $31.18 |
| Resistance Level | $5.36 | $33.17 |
| Average True Range (ATR) | 0.40 | 0.97 |
| MACD | -0.04 | -0.12 |
| Stochastic Oscillator | 9.43 | 16.37 |
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.